Page last updated: 2024-11-07

penicillamine and Cranial Nerve II Diseases

penicillamine has been researched along with Cranial Nerve II Diseases in 2 studies

Penicillamine: 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease.
penicillamine : An alpha-amino acid having the structure of valine substituted at the beta position with a sulfanyl group.

Research Excerpts

ExcerptRelevanceReference
"Optic neuropathy developed in a patient with rheumatoid arthritis who had been receiving D-penicillamine for about 1 year."7.67Optic neuropathy associated with penicillamine therapy in a patient with rheumatoid arthritis. ( Burde, RM; Klingele, TG, 1984)
"Optic neuropathy developed in a patient with rheumatoid arthritis who had been receiving D-penicillamine for about 1 year."3.67Optic neuropathy associated with penicillamine therapy in a patient with rheumatoid arthritis. ( Burde, RM; Klingele, TG, 1984)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Klingele, TG1
Burde, RM1
Lee, AH1
Lawton, NF1

Other Studies

2 other studies available for penicillamine and Cranial Nerve II Diseases

ArticleYear
Optic neuropathy associated with penicillamine therapy in a patient with rheumatoid arthritis.
    Journal of clinical neuro-ophthalmology, 1984, Volume: 4, Issue:2

    Topics: Arthritis, Rheumatoid; Fluorescein Angiography; Humans; Male; Middle Aged; Optic Nerve Diseases; Pap

1984
Penicillamine treatment of Wilson's disease and optic neuropathy.
    Journal of neurology, neurosurgery, and psychiatry, 1991, Volume: 54, Issue:8

    Topics: Adult; Color Perception; Dose-Response Relationship, Drug; Female; Hepatolenticular Degeneration; Hu

1991